3[3]Morino M,Giraudo G,Festa V.Alterations in hepatic function during laparoscopic surgery.Surg Endosc 1998,12:968.
二级参考文献7
1Gyr K, Meier R, Haussler J et al. Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomized, placebo controlled multicentre study. Gut, 1996, 39(2): 319
2Groeneweg M, Gyr K, Amrein R et al. Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial. Electroencephalogr Clin Neurophysiol, 1996, 98
3Barbaro G, Di Lorenzo G, Soldini M et al. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study. Hepatology, 1998, 28(2): 374
4Cadranel JF, el Younsi M, Pidoux B et al. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a doubleblind pragmatic randomized, placebo study. Eur J Gastroenterol. Hepatol, 1995, 7(4): 325
5Pomier-Layrargues G, Giguere JF, Lavoie J et al. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology, 1994, 19(1): 32
6Van der Rijt CC, Schalm SW, Meulstee J et al. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study. Gastroenterol Clin Biol, 1995, 19(6-7): 572
